Gu Oncology Now

Pioneering Advances in Bladder Cancer: New Drug Classes, Biomarkers, and Treatment Models 05:45
Pioneering Advances in Bladder Cancer: New Drug Classes, Biomarkers, and Treatment Models GU Oncology Now 46 9 дней назад
Long-Term Complications of Prostate Cancer Treatment: PSA Testing 09:18
Long-Term Complications of Prostate Cancer Treatment: PSA Testing GU Oncology Now 871 2 месяца назад
TALAPRO-2 and First-Line mCRPC Treatment: Insights on OS Benefits and Treatment Sequencing 07:35
TALAPRO-2 and First-Line mCRPC Treatment: Insights on OS Benefits and Treatment Sequencing GU Oncology Now 140 55 лет назад
Key Takeaways From ASCO GU 2025: TALAPRO-2, PSMA PET, and Emerging Treatments 04:22
Key Takeaways From ASCO GU 2025: TALAPRO-2, PSMA PET, and Emerging Treatments GU Oncology Now 169 55 лет назад
Identifying Castration Resistance in Prostate Cancer 05:26
Identifying Castration Resistance in Prostate Cancer GU Oncology Now 99 4 месяца назад
Key Trends and Emerging Research in the GU Oncology Landscape 08:15
Key Trends and Emerging Research in the GU Oncology Landscape GU Oncology Now 125 3 месяца назад
Bladder Cancer Breakthroughs: Insights from the NIAGARA Trial and Creatinine Cutoff Debate 05:58
Bladder Cancer Breakthroughs: Insights from the NIAGARA Trial and Creatinine Cutoff Debate GU Oncology Now 82 4 месяца назад
PENELOPE: TAR-200 Shows Deeper Tissue Penetration vs Standard Intravesical Therapy 09:18
PENELOPE: TAR-200 Shows Deeper Tissue Penetration vs Standard Intravesical Therapy GU Oncology Now 300 3 месяца назад
Radical Prostatectomy Versus Radiotherapy in High-Risk Prostate Cancer 12:41
Radical Prostatectomy Versus Radiotherapy in High-Risk Prostate Cancer GU Oncology Now 180 1 месяц назад
Doublet vs Triplet Therapy for mHSPC: Patient Selection and Treatment Considerations 11:00
Doublet vs Triplet Therapy for mHSPC: Patient Selection and Treatment Considerations GU Oncology Now 175 55 лет назад
From Vintage Imaging to Cutting-Edge Trials: The Future of Prostate Cancer Management 08:07
From Vintage Imaging to Cutting-Edge Trials: The Future of Prostate Cancer Management GU Oncology Now 317 55 лет назад
What’s Next for RCC Treatment? Promising New Targets and Clinical Trials 05:19
What’s Next for RCC Treatment? Promising New Targets and Clinical Trials GU Oncology Now 139 4 месяца назад
Strengthening Patient-Provider Relationships in Prostate Cancer Treatment 05:45
Strengthening Patient-Provider Relationships in Prostate Cancer Treatment GU Oncology Now 24 1 месяц назад
Changing Trends in Bladder Cancer: BCG, Precision Medicine, and Emerging Therapies 04:44
Changing Trends in Bladder Cancer: BCG, Precision Medicine, and Emerging Therapies GU Oncology Now 294 3 месяца назад
The Role of RCC Second-Line Therapy in Frontline Decision-Making: Does the Approach Matter? 09:26
The Role of RCC Second-Line Therapy in Frontline Decision-Making: Does the Approach Matter? GU Oncology Now 52 55 лет назад
LUGPA Bladder Cancer Highlights: Key Trials and Trends for 2025 05:58
LUGPA Bladder Cancer Highlights: Key Trials and Trends for 2025 GU Oncology Now 193 4 месяца назад
ASCO GU Research to Watch: Prostate Cancer 03:32
ASCO GU Research to Watch: Prostate Cancer GU Oncology Now 265 1 месяц назад
Disitamab Vedotin Plus Pembrolizumab in aUC: HER2 Status, Safety and Efficacy Data 08:23
Disitamab Vedotin Plus Pembrolizumab in aUC: HER2 Status, Safety and Efficacy Data GU Oncology Now 168 6 месяцев назад
Oligometastatic Prostate Cancer: Treatment Strategies and the Role of Local Therapy 11:02
Oligometastatic Prostate Cancer: Treatment Strategies and the Role of Local Therapy GU Oncology Now 243 55 лет назад

Сейчас ищут